Q-linea AB (publ) announced that Stuart Gander succeeds Jonas Jarvius as CEO. Stuart Gander brings extensive experience from leading positions in the global healthcare industry, with a focus on diagnostics and medical technologies. Through his management consulting background, he has supported companies on a range of operational challenges with a focus on driving sustainable change and growth, based on building strong and motivated teams. Stuart Gander is a Canadian citizen, has previously been working 15 years in Sweden, is currently living in the USA but will relocate to Sweden within the next 18 months.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.985 SEK | -1.97% |
|
-3.04% | +7.70% |
Jul. 02 | Q-linea Takes Part in First Belgian Public Tender for Rapid AST System | MT |
Jun. 28 | Q-linea AB Approves the Election of Jonas Jarvius as Members of the Board of Directors | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.70% | 44.41M | |
-30.79% | 15.65B | |
-57.58% | 2.09B | |
+19.25% | 1.88B | |
-18.17% | 1.36B | |
+25.65% | 1.28B | |
+2.06% | 798M | |
-33.66% | 762M | |
-36.55% | 724M | |
-30.00% | 586M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Q-linea AB Announces CEO Changes